J&J raises guidance for 2026 on strong start to the year
The healthcare giant saw sales of medications, which include Darzalex and Tremfya, increase 11% in the first three months of the year
Original Source
Read the full article at Marketwatch →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.